Capvizr
THE DEAL, AT A GLANCE

Altis Labs

From the announcement
01Who is involvedBacked by OrbiMed, Qiming Venture Partners USAFrom the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
02What happenedAltis Labs raised $25M Series A, announced 2026-09-17From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
03Why it mattersAltis Labs' $25M Series A is a below-median Healthcare & Life Sciences financing for an AI clinical trial endpoint, led by OrbiMed in a sector with 31 other trailing 30…From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗

Altis Labs · Financing Record

Explore source-linked visual explanations for Altis Labs. Unsupported claims are withheld while source review continues.

Record 12509 · Recorded date: 2026-09-17

Explore company records →
Free weekday briefing

Know which funding rounds matter before the first call.

Source-linked rounds, lead investors, and the signal behind the capital. One five-minute read.

Free · Unsubscribe anytime